Financial Reports

For further information, please contact:
Phone: +1(608)831-4445
Email: InvestorRelations@wi2wi.com

Financial Statements & MDA

2025

Financial Statements for the period ending June 30, 2025

MD&A for the period ending June 30, 2025 MDA

Financial Statements for the period ending March 31, 2025

MD&A for the period ending March 31, 2025 MDA

2024

Financial Statements for the period ending December 31, 2024

MD&A for the period ending December 31, 2024

Financial Statements for the period ending September 30, 2024

MD&A for the period ending September 30, 2024

Financial Statements for the period ending June 30, 2024

MD&A for the period ending June 30, 2024 MDA

Financial Statements for the period ending March 31, 2024

MD&A for the period ending March 31, 2024 MDA

2023

Financial Statements for the period ending December 31, 2023

MD&A for the period ending December 31, 2023

Financial Statements for the period ending September 30, 2023

MD&A for the period ended September 30, 2023

Financial Statements for the period ending June 30, 2023

MD&A for the period ended June 30, 2023

Financial Statements for the period ending March 31, 2023

MD&A for the period ended March 31, 2023

2022

Financial Statements for the period ending December 31, 2022

MD&A for the period ended December 31, 2022

Financial Statements for the period ending September 30, 2022

MD&A for the period ended September 30, 2022

Financial Statements for the period ending June 30, 2022

MD&A for the period ended June 30, 2022

Financial Statements for the period ending March 31, 2022

MD&A for the period ended March 31, 2022

2021

Financial Statements for the period ending December 31, 2021

MD&A for the period ended December 31, 2021

Financial Statements for the period ending September 30, 2021

MD&A for the period ended September 30, 2021

Financial Statements for the period ending June 30, 2021

MD&A for the period ended June 30, 2021

Financial Statements for the period ending March 31, 2021

MD&A for the period ended March 31, 2021

2020

Financial Statements for the period ending December 31, 2020

MD&A for the period ended December 31, 2020

Financial Statements for the period ending September 30, 2020

MD&A for the period ended September 30, 2020

Financial Statements for the period ending June 30, 2020

MD&A for the period ended June 30, 2020

Financial Statements for the period ending March 31, 2020

MD&A for the period ended March 31, 2020

2019

Financial Statements for the period ending December 31, 2019

MD&A for the period ended December 31, 2019

Q3 Financial Statements for the period ending September 30, 2019

Q3 MD&A for the period ended September 30, 2019

Q2 Financial Statements for the period ending June 30, 2019

Q2 MD&A for the period ended June 30, 2019

Q1 Financial Statements for the period ending March 31, 2019

Q1 MD&A for the period ended March 31, 2019

2018

Financial Statements for the period ending December 31, 2018

MD&A for the period ended December 31, 2018

Q3 Financial Statements for the period ending Sep 30, 2018

Q3 MD&A for the period ended Sep 30, 2018

Q2 Financial Statements for the period ending June 30, 2018

Q2 MD&A for the period ended June 30, 2018

Q1 Financial Statements for the period ending March 31, 2018

Q1 MD&A for the period ended March 31, 2018

2017

Financial Statements for the period ending December 31, 2017

MD&A for the period ended December 31, 2017

Q3 Financial Statements for the period ending September 30, 2017

Q3 MD&A for the period ended September 30, 2017

Q2 Financial Statements for the period ending June 30, 2017

Q2 MD&A for the period ended June 30, 2017

Q1 Financial Statements for the period ending March 31, 2017

Q1 MD&A for the period ending March 31, 2017

2016

Financial Statements for the period ending December 31, 2016

MD&A for the period ended December 31, 2016

Q3 Interim Financial Statements for the period ending September 30, 2016

Q3 MD&A for the period ended September 30, 2016

Q2 Interim Financial Statements for the period ending June 30, 2016

Q2 MD&A for the period ended June 30, 2016

Q1 Interim Financial Statements for the period ending March 31, 2016

Q1 MD&A for the period ended March 31, 2016

2015

Financial Statements for the period ending December 31, 2015

MD&A for the period ending December 31, 2015

Q3 Interim Financial Statements for the period ending September 30, 2015

Q3 MD&A for the period ending September 30, 2015

Q2 Interim Financial Statements for the period ending June 30, 2015

Q2 MD&A for the period ending June 30, 2015

Q1 Interim Finacial Statements for the period ending March 31, 2015

Q1 MD&A for the period ended March 31, 2015

2014

Audited annual financial statements

Q3 Interim Consolidated Financial Statements for the period ended September 30, 2014

Q3 MD&A for the period ended September 30, 2014

Q2 Interim Consolidated Financial Statements for the period ended June 30, 2014

Q2 MD&A for the period ended June 30, 2014

Q1 Interim Consolidated Financial Statements for the period ended March 31, 2014

2013

Audited Consolidated Financial Statements

Q3 Interim Consolidated Financial Statements for the period ended September 30, 2013

Q3 Management’s Discussion and Analysis, period ended September 30, 2013

Q2 Interim Consolidated Financial Statements for the period ended June 30, 2013

Q2 Management’s Discussion and Analysis, period ended June 30, 2013

Q1 Interim Consolidated Financial Statements for the period ended March 31, 2013

Q1 Management’s Discussion and Analysis, period ended March 31, 2013

2012

Annual Audited Consolidated Financial Statements December 31, 2012

MD&A for the year ended December 31, 2012

Q3 Interim Financial Statements for the period ending September 30, 2012

Q3 MD&A for the period ended September 30, 2012

Precision Devices Inc.